IL-28B/IFN-λ3 Drives Granzyme B Loading and Significantly Increases CTL Killing Activity in Macaques

IL-28B/IFN-λ3 Drives Granzyme B Loading and Significantly Increases CTL Killing Activity in Macaques
复制标题

DOI:
10.1038/mt.2010.118
复制
发表时间:
2010-09-01
期刊:
影响因子:
12.4
通讯作者:
Weiner, David B.
Weiner, David B.
中科院分区:
医学1区
文献类型:
--
作者:
Morrow, Matthew P.;Yan, Jian;Weiner, David B.

文献摘要

被引文献

相似文献

III型/λ干扰素(IFN)是在不到十年前发现的,目前仍处于表征过程中。虽然以前的研究集中在小动物模型中IFN-λ 3(也称为白细胞介素(IL)-28 B)的功能,但尚不清楚这些功能是否会转化为更大,更相关的模型。因此,在本研究中,我们使用DNA疫苗接种作为研究IFN-λ 3对恒河猴适应性免疫应答的影响的方法。我们的研究结果首次表明,IFN-λ 3对抗原特异性CD 8 + T细胞功能具有显著影响,特别是在细胞毒性方面。通过CD 107 a和颗粒酶B共表达以及穿孔素释放测定,给予IFN-λ 3的动物的外周CD 8 + T细胞显示出显著增加的细胞毒性应答。此外,从接受IFN-λ 3的动物的肠系膜淋巴结(MLN)分离的CD 8 + T细胞在延长的抗原刺激后负载显著量的颗粒酶B,并诱导显著更多的颗粒酶B介导的肽脉冲靶细胞死亡。这些数据表明,IFN-λ 3是免疫系统的有效效应子,特别强调CD 8(+)T细胞杀伤功能,这保证了作为可能的免疫佐剂的进一步研究。
Type III/lambda interferons (IFNs) were discovered less than a decade ago and are still in the process of being characterized. Although previous studies have focused on the function of IFN-lambda 3 (also known as interleukin (IL)-28B) in a small animal model, it is unknown whether these functions would translate to a larger, more relevant model. Thus in the present study, we have used DNA vaccination as a method of studying the influence of IFN-lambda 3 on adaptive immune responses in rhesus macaques. Results of our study show for the first time that IFN-lambda 3 has significant influence on antigen-specific CD8+ T-cell function, especially in regards to cytotoxicity. Peripheral CD8+ T cells from animals that were administered IFN-lambda 3 showed substantially increased cytotoxic responses as gauged by CD107a and granzyme B coexpression as well as perforin release. Moreover, CD8+ T cells isolated from the mesenteric lymph nodes (MLN) of animals receiving IFN-lambda 3 loaded significant amounts of granzyme B upon extended antigenic stimulation and induced significantly more granzyme B-mediated cell death of peptide pulsed targets. These data suggest that IFN-lambda 3 is a potent effector of the immune system with special emphasis on CD8(+) T-cell killing functions which warrants further study as a possible immunoadjuvant.